Influence of diabetes mellitus and nodal distribution in endometrial cancer and correlation to clinico-pathological prognostic factors

Objective: The aim of this study was to describe the relationships between the distribution of nodal disease, clinico-pathological patterns and recurrence and survival in surgically staged cases of endometrial cancer.

Methods: Charts were abstracted from patients with endometrial carcinoma from 1985 to 1995. Data on clinicopathologic variables, adjuvant treatment, site of recurrence and survival were collected. The chi square test was used to test associations between variables. The Kaplan-Meier method was used for survival analysis and Cox's proportional hazards model for multiple regression analysis.

Results: Sixty-nine out of 181 patients underwent lymph node dissection. Twenty-three had pelvic lymph node dissection, 23 underwent pelvic and paraaortic lymph node dissection and 20 patients had lymph node sampling. The median count of removed lymph nodes was 22.4. Fifty-four lymph node dissections showed negative lymph nodes and in 15 cases there was a minimum of one positive lymph node. Overall survival was in correlation to nodal involvement with a p value of 0.0017. Patients with lymph node involvement showed significantly more recurrence than patients with negative lymph nodes (p = 0.003). The depth of myometrial invasion correlated with lymph node metastasis (p = 0.01) and patients with additional diabetes mellitus showed significantly more nodal involvement (p = 0.02).

Conclusion: Endometrial cancer showed pelvic lymph node (PLN) and paraaortic lymph node (PALN) involvement. Under-diagnosis of the disease might result if there was only a PLN, but with or without PALN involvement there was no significant difference in overall survival or recurrence. There was an univariate correlation between lymph node involvement and diabetes.

Endometrial carcinoma; Nodal distribution; Clinico-pathological; Prognostic factor

[1] Lewis B.V., Stallworthy J.A., Cowell R.: "Adenocarcinoma of the body of the uterus". J Obstet. Gynecol. BR Cornrnonw, 1970, 77, 343.

[2] Morrow C.P., Bundy B.N., Kurman R.J., Creasman W.T, Heller P., Homesley H.D., Graham J.E.:''Relationship between surgicalpathological risk factors and outcome in clinical Stage I and II carcinoma of the cndometrium a Gynecology Oncology study group". Gynecol. Oncol., 1991, 40, SS.

[3] Creasman W.T: "Announcement: FIGO stages 1988 revisions" Gynecol. Oneal., 1989, 35, 125

[4] Kurman R.J., Zaino R.J., Norris H.J.: "Endometrial carcinoma" In: Kurman R.J. (ed.). Blaustein's Pathology of the Female Genital Tract, 4'h edition, New York, Springer, 1994.

[5] Sevin B.-U., Angioli R.: "Uterine corpus: Multimodality therapy in gynecologic oncology". New York, Thieme, 1996.

[6] McKeckin D.S., Lashbrook D., Gold M., Johnson G., Walker J.L., Mannel R.: "Analysis of FIGO lllc endometrial cancer patients". Gynecol. Oneal., 2001, 81, 273.

[7] Mariani A., Webb M.J., Rao S.K., Lesinick T.G., Podratz K.C. Gynecol. Oncol., 2001, 80, 113.

[8] Nagell J.R. Jr., Donaldson E.S., Parker J.C., van Dyke A.H., Wood E.G.:'The prognostic significance of pelvic lymph node morphology in carcinoma of the uterine cervix". Cancer, 1977, 39, 2624.

[9] Kauppila A., Gronroos M., Niemminen U.: "Clinical outcome in endometrial cancer". Obstet. Gynecol., 1982, 60, 473.

[10] Wagenius G., Strang P., Bergstrom R., Stendahl U., Tribukait B "Prognostic indices in endometrial adenocarcinoma Stages I and II". Anticancer Res., 1991, 11, 2137.

[11] EifeI P.J., Ross J., Hendrickson M., Cox R.S., Kempson R., Martinez A.: "Adenocarcinoma of the endometrium". Cancer, 1983, 52, 1026.

[12] Tabernero L.M., Alonso M.C., Ojeda B., Fuentes J., Balart J., Badia J. et al.: "Endometrial cancer Stages I and II". Eur. J Gynecol. Oncol., 1995, 16, 18.

[13] Malkasian G.D., Annegers J.F., Fountain K.S.: "Carcinoma of the endometrium Stage I". Arn. J. Obstet. Gynecol., 1980, 136, 872.

[14] Creasman W.T., Morrow C.P., Bundy B.N., Homesley H.D., Graham J.E., Heller P.B.: "Surgical pathological sread patterns of endometrial cancer: A GOG study". Cancer, 1987, 60, 2035.

[15] Vavra N., Denison U., Kucera H., Barrada M., Kurz C., Salzer H .. Sevelda P.: "Prognostic factors related to recurrent endometrial carcinoma following initial surgery". Acta Obstet. Gynecol Scand., 1994, 73, 730.

[16] Lurain J.R., Rice B.B.L., Rademaker A.W., Poggensee L.E., Schink J.C., Miller D.S.: "Prognostic factors associated with recurrence in clinical Stage I adenocarcinoma of the endometrium". Ob.stet. Gynecol., 1991, 78, 63.